Gimv invests in SpiraTec, a specialist in automation and digital transformation for the process industry
Gimv acquires a majority stake in SpiraTec AG (“SpiraTec”), a German provider of industrial automation, IT and engineering services for the pharmaceutical, chemical and wider process industries. Growing demand for secure, connected and AI-enabled production creates significant growth opportunities for SpiraTec as manufacturers invest in their long-term competitiveness. Founders and Co-CEOs Andreas Schadt and Frank Heines reinvest significantly and remain at the helm of the company. Together with Gimv, SpiraTec aims to accelerate its international growth, both organically and through acquisitions.
Founded in 2007 and headquartered in Speyer, SpiraTec AG (www.spiratec.com) designs, implements and optimises production processes for customers across a range of industries, including pharmaceuticals, biotechnology and chemicals. The company combines automation, IT and plant engineering into integrated end-to-end solutions, from consulting and planning through commissioning and validation to the maintenance and optimisation of operating production facilities. Its core markets are the pharmaceutical and chemical industries. Most projects focus on modernising and optimising existing facilities, fostering long-standing customer relationships.
SpiraTec has grown to around EUR 90 million in revenue and more than 650 employees at over 40 locations in Germany, France, Italy, Austria, Switzerland and the US. Alongside strong organic growth, the company has completed five acquisitions in Germany, Italy and Switzerland. With Gimv’s support, SpiraTec will continue its buy-and-build strategy and accelerate its expansion in Europe and the US. This investment fits well within Gimv’s Smart Industries platform, which focuses on companies that combine industrial and digital intelligence.
Ronald Bartel, Partner Smart Industries, declares: “SpiraTec has built an impressive track record over nearly two decades and has become a trusted partner for some of the most demanding production environments in pharma and chemicals. Its combined expertise in automation, IT and engineering provides a strong foundation for further growth and positions it well to help Europe’s advanced manufacturers adopt new technologies and strengthen their long-term competitiveness. We look forward to supporting Andreas, Frank and their team in the next phase of SpiraTec’s development, both organically and through acquisitions.”
Andreas Schadt and Frank Heines, founders and Co-CEOs of SpiraTec, add: “With Gimv, we have found a partner who shares our long-term vision and has extensive experience in supporting companies with their international expansion and buy-and-build strategies. Together, we will continue to grow SpiraTec as a reliable partner for our customers and an attractive employer for our people.”
The transaction is subject to customary conditions, including approval by the competition authorities, and is expected to close before the end of the year. This investment is in line with Gimv’s accelerated growth strategy of making larger individual investments in companies with strong international growth ambitions. No further financial details will be disclosed.